Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
7.60
+0.03 (0.40%)
At close: Oct 27, 2025, 4:00 PM EDT
7.70
+0.10 (1.32%)
Pre-market: Oct 28, 2025, 9:07 AM EDT
Niagen Bioscience Market Cap
Niagen Bioscience has a market cap or net worth of $607.39 million as of October 28, 2025. Its market cap has increased by 146.11% in one year.
Market Cap
607.39M
Enterprise Value
550.36M
1-Year Change
146.11%
Ranking
Category
Stock Price
$7.60
Market Cap Chart
Since June 25, 2008, Niagen Bioscience's market cap has decreased from $909.70M to $607.39M, a decrease of -33.23%. That is a compound annual growth rate of -2.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 603.70M | 48.99% |
| Dec 31, 2024 | 405.20M | 277.28% |
| Dec 29, 2023 | 107.40M | -14.15% |
| Dec 30, 2022 | 125.10M | -51.02% |
| Dec 31, 2021 | 255.40M | -13.89% |
| Dec 31, 2020 | 296.60M | 15.50% |
| Dec 31, 2019 | 256.80M | 35.87% |
| Dec 31, 2018 | 189.00M | -33.29% |
| Dec 29, 2017 | 283.30M | 125.74% |
| Dec 30, 2016 | 125.50M | -5.71% |
| Dec 31, 2015 | 133.10M | 41.45% |
| Dec 31, 2014 | 94.10M | -40.97% |
| Dec 31, 2013 | 159.40M | 224.64% |
| Dec 31, 2012 | 49.10M | 19.76% |
| Dec 30, 2011 | 41.00M | -49.88% |
| Dec 31, 2010 | 81.80M | 544.09% |
| Dec 31, 2009 | 12.70M | -95.35% |
| Dec 31, 2008 | 272.90M | -70.00% |
| Jun 25, 2008 | 909.70M | - |
View and export this data all the way back to 2008. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.49B |
| Johnson & Johnson | 456.78B |
| AbbVie | 402.74B |
| UnitedHealth Group | 329.89B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 219.14B |